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Among researchers, there has been a long-standing debate on the issue of whether  
alcohol and marijuana are used as substitutes or complements of one another. In  
other words, does the increased usage of one decrease the usage of the other  
(substitution) or does usage of both substances simultaneously increase  
(complements)? The primary purpose of this study is to identify whether a  
suggested substitution or complementary effect exists among adolescent drinking  
patterns following the recent emergences of increased marijuana legalization. To  
explore these effects, data is used from 38 different states included in the Youth  
Risk Behavior Surveillance System between the years 1995 and 2017. The  
primary analysis finds limited support for a substitution effect and no evidence of  
a complementary effect among adolescents. This study also includes a  
supplementary analysis providing implications for the direction of future research  
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1.1.  Introduction 
 
In recent years, the United States has seen a rapid emergence of marijuana 
legalization policies across a majority of states. Currently, ten states and the District of 
Columbia have adopted the most expansive laws legalizing marijuana for adult 
recreational use and retail sales. In these states, excluding the District of Columbia, 
marijuana is taxed and regulated similar to alcohol. Additionally, a total of twenty-three 
states have broadly legalized medical marijuana programs while an additional thirteen 
states have passed narrowly defined laws allowing the use of low delta-9-
tetrahydrocannabinol (THC), high cannabidiol (CBD) products for limited medical 
reasons. This sudden emergence of marijuana legalization raises a number of public 
health and safety concerns – particularly for youth and adolescents.  
Identifying and understanding the unintended consequences of these rapidly 
emerging policies is critical for a number of public health concerns. While the medicinal 
benefits of marijuana are becoming increasingly accepted, the controversy surrounding 
marijuana laws focuses primarily on the potential health risks associated with its use, 
particularly for adolescents. However, there is a substantial lack of evidence supporting 
these concerns. On the other hand, what is even less understood, is whether marijuana 
legalization influences usage rates of alcohol – a widely accepted, legal substance which 
is known to have detrimental effects on the physical, psychological, and social wellbeing 
of users. Among researchers, there has been a long-standing debate on the issue of 
whether alcohol and marijuana are used as substitutes or complements of one another. In 




(substitution) or does usage of both substances simultaneously increase together 
(complements)? If alcohol and marijuana are substitutes for one another, then laws that 
legalize the use of marijuana could potentially decrease the use of alcohol, presenting a 
major public health benefit. If they are complements, these laws could exacerbate alcohol 
usage. However, little up-to-date research has been done to observe this substitution or 
complementary effect in light of these modern policy changes. The primary purpose of 
this research is to identify whether a suggested substitution or complementary effect 
exists following the recent changes in many state’s laws. 
When considering the advantages and disadvantages of drug policy, it is critical 
for researchers and policy makers to approach topics from an unbiased and evidence-
based perspective. Thus, the structure of this thesis includes a comprehensive history of 
marijuana in the United States in order to establish a firm understanding of how 
American perceptions have evolved and contributed to the controversial political climate 
surrounding marijuana for generations. In addition, the health concerns associated with 
both marijuana and alcohol are included to allow the reader a full understanding of the 
known dangerousness associated with each substance. Once these contexts are 
established, I present the theoretical bases for the substitution and complement effects, 
pharmacological, and Rational Choice Theory.   
To explore these effects, data is used from the Youth Risk Behavior Surveillance 
System (YRBSS) between the years 1995 and 2017. Among these data are measures of 
adolescent alcohol and drug use from 38 different states. A better understanding of the 




surrounding the unintended public health consequences or benefits from an increase or 
decrease of usage rates associated with each substance. 
1.2  History of Marijuana in the United States 
 
 Hemp is an ancient plant that has been used and cultivated by humans for 
millennia. In the United States, hemp was encouraged by the federal government to be 
used in production for various products including rope, sails, and clothing throughout the 
17th Century (Herndon, 1963). The crop was a staple in colonial America and proved to 
be incredibly versatile in its uses, mostly due to its strong and durable fibers. The 
Virginia Assembly passed legislation in 1619 requiring every farmer to grow hemp, those 
who refused could be jailed (Herndon, 1963). In addition, hemp was often used to barter 
or even as legal tender for farmers to pay taxes in many colonies from 1631 until the 
early 1900s (Herndon, 1963). During the late 19th century, cannabis had become an 
increasingly popular ingredient in medical products and was openly available in drug 
stores (Siff, 2014). There were a number of medicinal fads throughout the century, often 
referring to cannabis as “a pleasurable and harmless stimulant” or a source for “new 
inspiration and energy”; however, recreational use was not widely known or accepted at 
this time (Siff, 2014; Vanity Fair, 1862). 
 Following the Mexican Revolution of 1910, the United States experienced an 
influx of Mexican immigrants, who ultimately introduced to American culture the 
recreational use of cannabis, which was referred to as “marihuana” (Siff, 2014; 
McDonald, 2017). The new and authentic sounding label of “marihuana” became 
increasingly associated with Mexican immigrants and quickly tied in with prejudice 




public and governmental concern about the usage of marijuana and sparked an uptick in 
anti-marijuana campaigns linking the substance to violence, crime, and other deviant 
behaviors which were primarily associated with the “racially inferior” (McDonald, 2017). 
The “war against marijuana” arguably began in 1930 with the establishment of the 
Federal Bureau of Narcotics and its first named director, Harry J. Anslinger. The agency 
of this time had numerous, racially charged claims intended to spread misinformation, 
referring to marijuana as “the most violence-causing drug in the history of mankind” and 
suggesting that “reefer makes darkies think they’re as good as white men” (McDonald, 
2017). While the fear mongering strategy seems outrageous, it worked as intended and 
newspapers were soon dubbing Mexican cannabis as the “Marijuana Menace” (Siff, 
2014; McDonald, 2017).  
By 1931, 29 states had outlawed marijuana and by 1937 Congress passed the 
Marijuana Tax Act, criminalizing marijuana and restricting possession of the drug only to 
those who paid an excise tax for medical and industrial uses (Marijuana Tax Act of 
1937). Sentencing laws grew even more strict by the Boggs Act (1952) and Narcotics 
Control Act (1956) – setting mandatory sentences for drug related offenses, including 
marijuana (Boggs Act of 1952; Narcotics Control Act of 1956). Under these sentences, 
there was a minimum sentence of 2-10 years with a fine of up to $20,000 for a first-
offense marijuana possession. Many of these mandatory penalties for drug-related 
offenses were eventually repealed by Congress in 1970 after the widespread 
acknowledgment that the mandatory minimum sentences did nothing to eliminate the 
popular drug culture of the 1960’s (Drug Abuse Prevention and Control Act of 1970). 




drug policy and the regulation of substances. The statute contains five schedules 
(classifications) qualifying drugs based off three factors: potential for abuse, accepted 
medical use, and potential for addiction. Under this act, marijuana was classified as a 
Schedule I drug, the most restrictive and high-risk category. 
 In 1971 President Nixon declared the first “war on drugs” and further increased 
the size and presence of federal drug control agencies (Drug Policy Alliance, 2019). In 
addition, public concern over marijuana use continued to increase as a nationwide 
parents’ movement against marijuana emerged in 1976 throughout the 1980’s, lobbying 
for stricter regulations of marijuana and prevention of teenage drug use (Dufton, 2013; 
Drug Policy Alliance, 2019). Many of the groups became increasingly influential on 
public attitudes and also gained support from the Drug Enforcement Administration 
(DEA) and the National Institute on Drug Abuse (NIDA) (Dufton, 2013; Drug Policy 
Alliance, 2019). Among eleven states, there was a brief emergence of decriminalization 
proposals which were readily abandoned as progress continually shifted under an 
unprecedented expansion of the drug war by President Ronald Reagan. The late 1980s 
consisted of a dramatic increase of political hysteria regarding drug abuse: polls in 1985 
reflected only around 2 to 6 percent of Americans who saw drug abuse as the nation’s 
“number one problem”, within four years these numbers reached 64 percent – this shift is 
known as one of the most intense fixations by the American public in polling history 
(Drug Policy Alliance, 2019).  
 In 1986, the Anti-Drug Abuse Act was signed by President Ronald Reagan, 
implementing mandatory sentences for drug related crimes (Anti-Drug Abuse Act of 




which raised federal penalties for marijuana possession and dealing (Comprehensive 
Crime Control Act of 1984). These penalties were calculated based off the amount of the 
drug involved, rather than the type of substance. Under these definitions, the possession 
of 100 marijuana plants received the same penalty as 100 grams of heroin. The Anti-Drug 
Abuse Act would later be amended to establish a “three strikes and you’re out” policy, 
requiring life sentences for repeat drug offenders and allowing the death penalty for 
“drug kingpins” (Omnibus Anti Drug-Abuse Act of 1988). The war on drugs proceeded 
to expand throughout the 1990s under the presidency of Bill Clinton. While the public 
outcry surrounding drug use eventually waned, the draconian style policies enacted 
during the time of political hysteria remained – contributing to escalating levels of arrests 
and incarceration (Drug Policy Alliance, 2019).   
Nearing almost 100 years since the very beginnings of a movement which 
criminalized marijuana in the early 20th Century, California was the first state to once 
again legalize the medicinal use of marijuana in 1996 with Proposition 215 (The 
Compassionate Use Act of 1996). This allowed the sale of marijuana to patients with 
AIDS, cancer, and other serious and painful diseases. Since then, 33 more states, the 
District of Columbia, Guam, and Puerto Rico have enacted similar laws for medical 
marijuana, decriminalization efforts, and even recreational use.  
1.3.  Current Federal Laws 
Currently, marijuana still remains classified as a Schedule I drug by the federal 
government, making the distribution of marijuana a federal offense. According to the 




“no currently accepted medical use in treatment in the United States” (DEA, 2018; 
Anderson et. al, 2001). 
In 2009, the Obama Administration encouraged federal prosecutors not to 
prosecute people who distribute marijuana for medical purposes in accordance with state 
laws. By 2013, the United States Department of Justice (USDOJ) updated their marijuana 
enforcement policy with the Cole Memorandum, stating that while marijuana remains 
illegal federally, the USDOJ expects states which pursue legalization to create “strong, 
state-based enforcement efforts.... and will defer the right to challenge their legalization 
laws at this time.” However, the department does reserve the right to challenge states at 
any time if deemed necessary (Cole, 2013). 
 In more recent events, Attorney General Sessions issued a Marijuana 
Enforcement Memorandum which rescinded the Cole Memorandum, allowing federal 
prosecutors the discretion on how to prioritize enforcement of federal marijuana laws. 
The Sessions memorandum instructs U.S. Attorney’s to “weigh all relevant 
considerations, including federal law enforcement priorities set by the Attorney General, 
the seriousness of the crime, the deterrent effect of criminal prosecution, and the 
cumulative impact of particular crimes on the community.” 
1.4.  Current State Laws 
 
With marijuana remaining a Schedule I drug under federal law the discrepancies 
between state laws which are pursuing legalization efforts are abundant. For instance, 
medical marijuana cannot legally be “prescribed” under its current definition as a 
Schedule I drug with “no currently accepted medical use in treatment” – rather these 





states with medical marijuana programs typically have some form of patient registry, 
which may provide individuals with some legal protection for possession up to a certain 
amount of marijuana.  
While marijuana laws are rapidly changing and vary by state, they can be 
condensed into three general categories: legal, medical, and illegal. Currently, 
recreational marijuana is legal in ten states and the District of Columbia, which allow for 
recreational adult use and medical use programs (National Conference of State 
Legislatures, 2018; Marijuana Policy Project, 2018). In all of these states, excluding 
Vermont and the District of Columbia, marijuana is taxed and regulated similar to 
alcohol. A total of twenty-three states allow comprehensive medical marijuana/cannabis 
programs while an additional thirteen states allow use of “low THC, high CBD” products 
for limited medical reasons. While these states have some form of a medical program, the 
laws still vary significantly, and the general decriminalization of marijuana is still mixed 
amongst these states. For example, while some states may have legalized a medical 
marijuana program, the possession, use, and/or distribution of marijuana for individuals 
without a medical license is still illegal and may still be punishable by fines and/or 
imprisonment (Marijuana Policy Project, 2019).  Lastly, Idaho, South Dakota, Nebraska, 
and Kansas are the final four states where all forms of marijuana use or programs are 
currently illegal, including access to “low THC, high CBD” products. 
Furthermore, while the research on the relationship between marijuana and 
alcohol use is still in its early stages, some current laws intend to limit the use of both 




alcohol at the same location1 (Medical and Adult-Use Cannabis Regulation and Safety 
Act of 2017). Some laws also prohibit the consumption of cannabis in public places, 
including locations authorized to sell or serve alcohol. Further, the sale of cannabis 
infused (or mixed) alcoholic beverages is also prohibited (California Department of 
Public Health, 2017).  
With the recent increases of decriminalization, medical marijuana licenses, and 
recreational marijuana laws across the United States a number of public health and policy 
questions are brought to the forefront. While there is growing support on the medical 
properties’ marijuana may have to offer, the research underlying the potential health risks 
is limited. Furthermore, as marijuana becomes more accessible for recreational use, 
knowledge on other unintended consequences is mixed, including the impacts of usage 
rates on other more dangerous substances. 
2. Marijuana and Alcohol 
 
 2.1.  Marijuana 
2.1.1.  Gateway Drug 
 Marijuana has long been referred to as “the gateway drug” – implying that those 
who choose to use marijuana will eventually go on to use other, harder drugs. While this 
argument is supported by animal studies, which have shown that early exposure to 
addictive substances may change how the brain responds to drugs and enhance the 
experience for other addictive substances, statistics for humans consistently report that a 
majority of people who use marijuana never go on to use harder drugs (Drug Policy 
Alliance 2018; Panlilio, Zanettini, Barnes, Salinas, & Goldberg, 2013). A number of 




is a gateway drug and findings are typically overstated and/or inconclusive (Caulkins, 
Kilmer, & Kleiman, 2016). Nonetheless, when taking into account a person’s risk for 
drug use and addiction, researchers should consider more than just biological 
mechanisms, other factors should be taken into account such as a person’s social 
environment, genetics, psychological and personality traits (Kreek, Nielsen, Butelman, & 
LaForge, 2005).  
 While there is not ample evidence to support marijuana as a gateway drug, other 
related factors should not be dismissed that could contribute to a “gateway effect”. For 
example, using marijuana could increase an individual’s desire to seek mind altering 
drugs or infer that drugs are less risky than previously supposed (Caulkins, Kilmer, & 
Kleiman, 2016). This could potentially influence an individual’s decision to partake in 
harder drugs. In addition, the social interactions that come with marijuana use may 
increase contact with peers who favor drug use (Caulkins, Kilmer, & Kleiman, 2016). 
These interactions could also increase the opportunity to access other illegal drugs. 
However, legalizing marijuana could interfere with this relationship by removing 
marijuana from the supply chain in the underground market. In other words, 
decriminalizing marijuana would interfere with the criminal, social influences which 
might contribute to a gateway effect. 
 Overall, the question of increased drug dependency following marijuana use may 
indeed be possible but is yet to be proven. While evidence suggests that adolescents who 
use marijuana are more likely to go on to use other drugs than their abstinent peers, the 




use of other drugs in general (Secades-Villa, Garcia-Rodriguez, Jin, Wang, & Blanco, 
2015; Levine, Huang, & Drisaldi, 2011). 
2.1.2.  Marijuana Medicinal Qualities 
 
 The marijuana plant contains more than 100 cannabinoids, which are the 
chemicals that include delta-9-tetrahydrocannabinol (THC), marijuana’s primary 
psychoactive ingredient which is responsible for the “high” that users experience 
(National Institute of Drug Abuse, 2018). There are currently two main cannabinoids of 
medical interest from marijuana, THC and Cannabidiol (CBD). While THC does have a 
mind-altering effect, it has also been linked to decreasing pain, inflammation, muscle 
control problems, increased appetite and reduced nausea (NIDA, 2018). Unlike THC, 
CBD does not have an intoxicating effect on people and is thus not popular for 
recreational use but is still often used for various medical purposes including: reducing 
pain and inflammation, epileptic seizures, and possibly treating mental illness and 
addiction (NIDA, 2018). 
After the passage of California’s Proposition 215, the Institute of Medicine 
released a report exploring the therapeutic uses of marijuana. The report found that: 
“Scientific data indicate the potential therapeutic value of cannabinoid drugs, primarily 
THC, for pain relief, control of nausea and vomiting, and appetite stimulation; smoked 
marijuana, however, is a crude THC delivery system that also delivers harmful 
substances. The psychological effects of cannabinoids, such as anxiety reduction, 
sedation, and euphoria can influence their potential therapeutic value. Those effects are 
potentially undesirable for certain patients and situations and beneficial for others. In 




drug's effect.” (NCSL, 2018, p. 4). Since then, other studies have since found further 
evidence of the effectiveness of marijuana for medical uses. In early 2017, the National 
Academies of Sciences, Engineering, and Medicine released a report constructed of a 
review of over 10,000 scientific studies on marijuana health research. The final report 
obtains 100 conclusions related to health (Committee on the Health Effects of Marijuana, 
2017). In summary, there is substantial evidence for cannabis to be used as effective 
treatment in relieving chronic pain, nausea and vomiting, and improving patient-reported 
multiple sclerosis spasticity symptoms. There is also moderate evidence for cannabis to 
be effective in improving short-term sleep outcomes for various causes of sleep 
disturbances. Lastly, there is limited evidence for the improvement of symptoms of 
Tourette syndrome, anxiety symptoms, posttraumatic stress disorder, and better outcomes 
following a traumatic brain injury or intracranial hemorrhage. 
While the evidence of the therapeutic uses of marijuana is increasing, researchers 
have not yet conducted enough large-scale clinical trials to establish FDA approval that 
the benefits outweigh the risks in patients. For current medical marijuana patients, 
treatment recommendations are primarily up to the “budtenders” – or dispensary staff – 
to make product suggestions for patients. Since the therapeutic benefits of marijuana are 
still subjective, it is somewhat of an arbitrary process with no formal guidelines. 
However, the FDA does support current research of well-controlled clinical trials making 
efforts to develop safe and effective marijuana products to treat medical conditions 
(NCCIH, 2018). The FDA has currently approved three cannabinoids as drugs. Epidiolex, 
contains CBD derived from the marijuana plant for the treatment of seizures associated 




dronabinol and nabilone – have also been approved to treat nausea and vomiting from 
chemotherapy (NCCIH, 2018). Dronabinol has also been approved to treat loss of 
appetite and weight loss in people with AIDS (NCCIH, 2018). While research for 
medical uses of marijuana is increasingly gaining attention, there is still much that is 
largely unknown about the true medicinal qualities of the plant.  
Nonetheless, the legalization of medical marijuana has provided other indirect 
pharmaceutical benefits. Since the late 1990’s, opioid misuse and addiction has become a 
widespread issue in the United States. In 2017, opioid overdoses accounted for more than 
47,600 deaths – averaging 130 deaths per day – and it is estimated that approximately 
11.4 million people misused prescription opioids (U.S. Department of Health and Human 
Services, 2018). The U.S. Department of Health and Human Services has since declared 
the opioid crisis a public health emergency. Opioids are typically prescribed for the 
management of chronic pain; which is also a major indication for medical cannabis. 
Following medical marijuana legalization laws, research has begun to explore the impact 
of medical marijuana on opioid use and mortality rates. One study has found that states 
with medical marijuana laws are associated with significantly lower opioid overdose 
mortality rates and the relationship appears to strengthen overtime (Bachuber, Saloner, 
Cunningham, & Barry, 2014). More recently, other studies have further explored this 
relationship to identify the potential mechanism that facilitates the decrease in opioid 
overdose deaths and the reduction of daily doses filled (Powell, Pacula, & Jacobson, 
2018). Findings suggest that broader access to medical marijuana facilities and more 
liberal allowance for dispensaries facilitate the substitution of marijuana for opioids 




dispensaries remove this protective factor among states (Powell et al., 2018). Apart from 
overdose related deaths, the legalization of medical marijuana has also been associated 
with a decrease in traffic fatalities involving drivers testing positive for opioid use, 
between the ages of 21 to 40 years (Kim, Santaella-Tenorio, Mauro, Wrobel, Cerda, 
Keyes, Hasin, Martins, & Li, 2016). In summary, while the medical properties of 
marijuana are still being studied, there is limited support suggesting evidence of 
additional indirect benefits of medical marijuana legalization if it is indeed being used to 
substitute for suggestively much more harmful pharmaceuticals.  
2.2.  Health Concerns 
2.2.1.  Marijuana 
 The Substance Abuse Center for Behavioral Health Statistics and Quality reported 
from the 2016 National Survey on Drug Use and Health that marijuana is the most 
commonly used illicit substance in the United States, including young adults aged 18 to 
25. However, there are no recorded instances of fatal overdoses from marijuana alone 
(NIDA, 2018).  
Marijuana has a number of short-term effects on various parts of the brain, 
causing the reported “high” consumers seek. The effects generally include altered senses, 
altered sense of time, changes in mood, impaired body movement, difficulty thinking and 
problem-solving, and impaired memory (NIDA, 2018). If taken in high dosages, 
individuals could potentially experience hallucinations, delusions, or psychosis – 
particularly for those with an established psychotic disorder (Wilkinson, 2014; NIDA, 




the majority of individuals who consume cannabis do not experience any kind of 
psychosis (Radhakrishnan et al., 2014).  
However, use of cannabis during adolescents has been linked to adult onset-
psychosis. Caspi et al. (2005) found evidence that adolescent-onset cannabis use is 
associated with a functional polymorphism in the catechol-O-methyltransferase gene 
predicted the risk of psychosis in adulthood. However, this relationship was not found 
among individuals who began to use marijuana as adults. The authors also acknowledge 
the possibility that preexisting cognitive problems could lead psychosis-prone individuals 
to initiate cannabis use as teenagers. Nonetheless, these findings suggest that some 
adolescents could be neurobiologically vulnerable to cannabis, which should be taken 
into consideration when designing policy that affects adolescent access to marijuana 
(Caspi et al., 2005).  
 As for the physical effects of marijuana use, reported instances include increased 
heart rate for up to 3 hours after smoking, nausea, vomiting, and breathing problems for 
people who smoke marijuana frequently (NIDA, 2018; National Academies of Sciences, 
Engineering, and Medicine, 2017). While many of these symptoms are comparable to 
tobacco smokers, research has yet to find any higher risks for lung cancer in people who 
smoke marijuana than cigarettes (NIDA, 2018; NASEM, 2017). Studies on the mental 
effects of marijuana are mixed but have been linked to mental illnesses in some people, 
such as: temporary hallucinations, temporary paranoia, and worsening symptoms in 
patients with schizophrenia (NIDA, 2018). Marijuana has also been linked to depression, 




The addictiveness of marijuana is frequently debated as well. Within the United States, 
the THC-potency has continually increased between the years 2001 to 2013 and the 
prevalence of past-year adult marijuana use more than doubled, however the risk of 
marijuana use disorders has slightly declined (Hasin, Saha, & Kerridge, 2015).  Overall, 
this research suggests that between 9 and 30 percent of marijuana users may develop 
some degree of marijuana use disorder (Hasin, Saha, & Kerridge, 2015). Those who use 
marijuana long term and try to quit have reported mild withdrawal symptoms such as: 
grouchiness, sleeplessness, decreased appetite, anxiety, and cravings (NIDA, 2018). 
The long-term effects of marijuana are still often debated and are currently 
heavily researched. However, a number of studies have investigated the long-term effects 
of adolescent-onset marijuana use on impairments of thinking, memory, and learning 
functions (NIDA, 2018; Meier, Caspi, & Ambler, 2012; Jackson, Isen, Khoddam, Irons, 
Tuvblad, Iacono, McGue, Raine, & Baker, 2016). One example includes a study in New 
Zealand which tested the association between persistent cannabis use and 
neuropsychological decline in order to determine whether decline is concentrated among 
adolescent-onset cannabis use (Meier et al., 2012). Findings suggest that people who 
heavily used marijuana in their teenage years and had an ongoing marijuana use disorder 
lost an average of 8 IQ points between ages 13 and 38 – which did not later return for 
those who quit marijuana as adults. The neuropsychological decline persisted broadly 
across domains of functioning, even when controlling for years of education (Meier et al., 
2012). Contrarily, consumers who started smoking marijuana as adults did not show any 
significant IQ declines (Meier et al., 2012). Another recent study exploring the long-term 




adolescence causes neurocognitive decline (Jackson et al., 2016). This study included 
twin sets of users and non-users, controlling for genetic propensity and shared 
environment to determine the direct feasibility of a direct mechanism underlying the IQ-
marijuana use association. While the study found a significant decline in general 
knowledge and verbal ability (approximately 4 IQ points) for marijuana users between 
the preteen years and early adulthood, future users already had significantly lower scores 
than nonusers at the baseline assessments – demonstrating that marijuana use may not 
necessarily precede lower IQ (Jackson et al., 2016).  When comparing any changes in IQ 
since the baseline assessment, no predictable effects consistently emerged to suggest that 
the marijuana using twin exhibited greater IQ deficits relative to their marijuana-abstinent 
twin (Jackson et al., 2016). These findings suggest that the suspected IQ deficit in early 
marijuana users could be attributable to confounding factors which may influence both 
substance use initiation and IQ (Jackson et al., 2016). Nonetheless, further research is 
necessary to understand the suggestive effects of cannabis on the adolescent brain and 
highlight the importance of effective marijuana policy efforts with respect to adolescents. 
In summary, while the health consequences of marijuana are still being heavily 
studied and the conclusions are generally mixed, the health concerns associated with 
alcohol use have long been understood by researchers.  
2.2.2.  Alcohol 
The National Institute of Alcohol Abuse and Alcoholism reports estimate that of 
88,000 people die from alcohol-related causes annually, making alcohol the third leading 




are from alcohol poisoning alone – an average of 6 deaths each day (Center for Disease 
Control and Prevention, 2018). 
Drinking too much (binge drinking) has been heavily researched and shown to 
cause a number of serious health consequences. While the definition of binge drinking 
varies, for this particular data set, binge drinking is defined as consuming five or more 
alcoholic drinks, in a row, within approximately two hours (for males) or four or more 
alcoholic drinks in a row, within two hours (for females) (CDC, 2018). Alcohol 
consumption at this level typically result in acute impairment and contributes to a 
substantial proportion of all alcohol related deaths (Naimi, 2003). Other adverse health 
effects associated with binge drinking include: unintentional injuries (e.g., motor vehicle 
crashes, falls, drowning, hypothermia, and burns), suicide, sudden infant death syndrome, 
alcohol poisoning, hypertension, acute myocardial infarction, gastritis, pancreatitis, 
sexually transmitted diseases, meningitis, and poor control of diabetes (Naimi, 2004; 
NIAAA, 2018). Binge drinking can also lead to a number of social and economic 
consequences including interpersonal violence (e.g., homicide, assault, domestic 
violence, rape, and child abuse), fetal alcohol syndrome, unintended pregnancy, child 
neglect, and lost productivity (NIAAA, 2018; Naimi, 2003). The United States 
Department of Health and Human Services noted that reducing binge drinking among 
adults is one of the leading health indicators in Healthy People 2010 (USDHHS, 2010). 
Furthermore, a number of previous studies have consistently found binge drinking rates 
to be highest among young adults aged 21 to 25 years and underage drinkers aged 18 to 
20 years (Kanny, Kaimi, Liou Lu, & Brewer, 2015; Naimi, 2003; Greenfiel, Midanik, & 




The long-term effects of heavy alcohol use have been shown to weaken the 
immune system and cause permanent damage to the heart including problems such as: 
cardiomyopathy, arrhythmias, stroke, and high blood pressure (NIAAA, 2018). The liver 
also commonly experiences problems with long term drinking such as: steatosis, 
alcoholic hepatitis, fibrosis, and cirrhosis (NIAAA, 2018). Alcohol has also been shown 
to cause the pancreas to produce toxic substances that may eventually lead to pancreatitis. 
(NIAAA, 2018). There is also a strong scientific consensus based on extensive reviews of 
research studies of clear patterns between alcohol consumption and the development of 
several types of cancer including: head and neck cancer, esophageal cancer, liver cancer, 
breast cancer, and colorectal cancer (National Cancer Institute, 2018). 
Alcoholism is currently considered a dire public health concern, and one of the 
most common addictions affecting Americans with reports of more than 15 million 
people struggling with alcohol use disorder – with less than 8% of these receiving 
treatment (NIAAA, 2018). Addictions are usually formed once an individual’s brain 
adapts to the psychological effects of alcohol and thus the brain needs more alcohol to 
experience the same effect (Delphi Behavioral Health Group, 2018). This process creates 
an ongoing cycle of increasing one’s tolerance, contributing to greater alcohol 
consumption in order to achieve the desired effects. Eventually, this cycle is likely to lead 
to alcohol dependence and addiction. Withdrawal symptoms upon quitting can begin to 
occur as early as two hours after a last drink and may include: insomnia, agitation, 
headaches, anxiety, nausea, rapid heartbeat, changes in blood pressure, sweating, fever, 
tremors, hallucinations, and seizures or convulsions (Delphi Behavioral Health Group, 




the more serious of these effects. These immediate symptoms often progress over a 48-
hour timeline and can be experienced again within the first couple weeks after quitting. 
Others may experience more prolonged side effects that can last anywhere from a few 
weeks to a year with symptoms including: irritability or emotional outbursts, anxiety, low 
energy, trouble sleeping, memory problems, dizziness, increased accident proneness, and 
delayed reflexes (Delphi Behavioral Health Group, 2018).  
2.3.  Relationship Between Alcohol and Marijuana 
Alcohol and marijuana are two of the most commonly used substances in the 
world and have comparable psychological effects upon consumption (SAMHSA, 2012; 
Wen et al., 2015). One can acknowledge that each substance poses their own set of health 
risks; however, even with the limited research on marijuana, it is clear that the risks 
associated with alcohol can be extremely detrimental. With the legalization of marijuana, 
the substance is becoming more accessible to the public and thus more likely to be 
obtained by adolescents.  While many may be quick to assume that a potential rise in 
marijuana usage rates could be inherently harmful for adolescents and public health, 
previous research suggests that there is potential for this to lead to a decrease in alcohol 
consumption, if the substances are indeed substitutes of each other. When taking into 
account the public health crisis that has resulted from alcohol abuse and alcoholism, a 
substitution effect with marijuana could arguably present a major public health benefit. 
Alcohol use has undeniably been associated with multiple, permanent health problems 
and remains as one of the most common addictions, accompanied by aggressive 
withdrawal symptoms. While a substitution effect may have an impact on overall alcohol 




major proportion of all alcohol related deaths. Underage adolescents and young adults 
reportedly have the highest rates of binge drinking across all age groups; thus, it is critical 
to public health for policy makers to understand how the legalization of marijuana 
impacts adolescent drinking habits. Researchers across various disciplines have already 
investigated if such an effect exists between alcohol and cannabis; however, results have 
remained mixed and a consensus has yet to be synthesized. A number of studies have 
found support suggesting that these substances are indeed substitutes for one another 
(Anderson, Hansen, & Rees, 2001; DiNardo & Lemieux, 2001; Crost & Guerrero, 2012; 
Chaloupka & Laixuthai, 1997). However, several studies have also found that alcohol use 
complements marijuana use, which, if true, would enhance the damages associated with 
increased alcohol and marijuana use (Pacula, 1998; Yörük and Yörük, 2011; Williams, 
Pacula, Chaloupka, & Wechsler, 2004). Overall, there is still much ambiguity across 
findings of this phenomenon.  
2.4.  Substitutes and Complements 
2.4.1.  Pharmacological Theory 
Among researchers, there has been a long-standing debate on the issue of whether 
alcohol and marijuana are used as substitutes or complements of one another (Anderson, 
Hansen, & Rees, 2001). In general, a “substitute” is something that takes the place of 
something else, whereas a “complement” is something that completes or enhances 
something else. These definitions can be applied to the categorization of drugs based on 




enhance the effects of one drug with another, and “independent” if the effects of one drug 
are unaltered by the other (Subbaraman, 2016).  
Marijuana and alcohol both target some of the same neural pathways in the 
human brain, which may result in similar psychological effects when using each 
substance (SAMHSA, 2012; Wen et al., 2015). More specifically, marijuana use 
produces similar rewarding and sedative effects, which are comparable to the effects of 
alcohol, particularly low-dose alcohol consumption (Wen et al., 2015). It is also worth 
mentioning that only extreme use of marijuana is shown to produce mild hangover 
effects, whereas mild-to-moderate alcohol consumption can produce debilitating 
hangover effects (Jones & Jones, 2019). Given these comparable effects in conjunction 
with the lower costs of marijuana following legalization, an individual may choose to 
substitute marijuana for alcohol to achieve a similar experience with less immediate 
consequences.  
Contrarily, evidence also suggests that the overall intoxication experience may be 
enhanced by simultaneously using marijuana and alcohol together– suggesting that the 
substances are complements. Previous studies have found that ethanol, especially when 
consumed in high doses can facilitate an increased absorption of THC, resulting in an 
increase of the positive subjective mood effects of marijuana (Boys, Marsden, & Strang, 
2001; Lukas and Orozco (2001). Furthermore, Lukas and Orozco (2001) conducted a 
randomized control experiment, which found that those participants which consumed 
marijuana simultaneously with high doses of ethanol reported more episodes and longer 




following simultaneous consumption with high doses of alcohol could produce an urge 
for the consumer to drink even more (Wen et al., 2015). Such a scenario of 
complementary substances presents a direct competing hypothesis for a substitution 
effect. Thus, it is possible that the increased legalization and accessibly to marijuana may 
result in an increase of usage of both substances.  
When considering the pharmacological effects on researching whether alcohol 
and marijuana are substitutes or complements, it is important to keep in mind that 
individual motives may also influence substance use patterns. For example, individuals 
seeking more mild effects of euphoria or relaxation may choose to partake in the 
consumption of one substance over the other. Whereas those seeking more intense 
euphoric or intoxicating effects would consume the substances together, potentially in 
higher doses. In addition, when substances become accessible and more normalized 
under liberalized policies, the perceived costs associated with usage tends to decrease, 
thus potentially influencing the likelihood of usage. While the substances have 
comparable psychological effects, it is sensible to assume that there is still a decision-
making process that takes place when an individual is given the option of two accessible 
substances. 
2.4.2.  Rational Choice Theory 
 The rational choice model of deviant behavior and drug use explains an 
individual’s drug use as a result of the decision-making process through a cost-benefit 
analysis (Black & Joseph, 2013). According to this theory, drug use will occur when the 
perceived benefits of engaging in the activity are greater than the risks associated with it. 




affected by incentives and constraints – both of which are taken into consideration in the 
individual’s subjective yet rational calculation of reward, risk, and punishment (Black & 
Joseph, 2013). Laws criminalizing drug use are in part a strategy of deterrence intended 
to maximize the costs of engaging in the behavior, thus reducing the prevalence of drug 
use. However, one could argue that criminalization laws have been shown to be rather 
ineffective at eliminating marijuana consumption (Bostwick, 2012). Even with the 
current expansion of more liberalized policies, marijuana is still criminalized in many 
states yet remains as the most popular illicit substance (NIDA, 2018).  
 In the case of substance use, rewards of the activity may be inherit to the 
pleasures associated with the experience of consumption. On the other hand, the risks of 
substance use may be more subjective based on the perception of the number of risky 
factors associated with use, such as the likelihood of getting caught and the level of 
negative sanctions. Both formal and informal sanctions can be taken into account with 
this theory. Formal sanctions include actions that are typically defined by policy, 
enforced, and official in nature such as arrest, citations, or job loss (Black & Joseph, 
2013). Informal sanctions are not laws, in a legal sense, but occur regularly in society 
such as shaming, ridicule, or disapproval by peers (Bottorff et al. 2013). These informal 
sanctions may be of particular importance when trying to understand an adolescent’s 
rationale to partake in substance use, as disapproval from peers could deter drug use 
(risk) but also promote it through the possibility of peer pressure one may experience if 
trying to “fit in” (reward). While these calculations are entirely subjective to the 




associated with the drug-use behavior, the greater chance that person will engage in 
consumption (Bostwick, 2012; Black & Joseph, 2013).  
 When the law changes in a certain way, it creates the opportunity of a chain of 
events to occur and influence one’s decision to partake in substance use. Some of these 
may take place immediately and some may occur over a more extended amount of time. 
For adolescents living in states with more liberalized marijuana laws, the perceived risks 
associated with access, usage, and getting caught are likely to decrease almost 
immediately. For example, for states which marijuana is still illegal, access to the 
substance requires a connection to a dealer. The process of distributing and maintaining 
illegal substances carries an additional standard of risk than obtaining alcohol.  In 
recreational states, marijuana use is essentially placed on the same level of risk as 
alcohol, with criminality only reaching the extents of a “minor-in-possession” status 
offense to those under 21 years of age (State of Colorado, 2019). Furthermore, 
legalization efforts may contribute to a community with an increase in accepting attitudes 
and normalization of marijuana, thus the social costs associated with usage will begin to 
drop. In other words, the negative stigma and consequences that are normally associated 
with using illicit drugs are becoming less applicable to marijuana following policy 
changes. 
Some studies have already begun to suggest the beginning of this process by 
measuring changes in attitudes following marijuana policy changes amongst states. One 
study, analyzed attitudes towards marijuana of 8th, 10th, and 12th graders in California 




Schulenberg, & Patrick, 2015). The study found an increase in permissive attitudes 
toward marijuana among 12th graders (Miech et al., 2015). These attitudes were measured 
using survey response questions regarding: using marijuana in the last 30 days, 
perceptions of regular marijuana use as a great health risk, disapproval of regular 
marijuana use, and expectations to use marijuana five years in the future. Another study, 
using the National Survey on Drug Use and Health (2003-2011) also tested for temporal 
changes of attitudes following the commercialization of marijuana in Colorado 
(Schuermeyer, Salomonsen-Sautel, Price, Balan, Thurstone, Min, & Sakai, 2014). The 
results showed that marijuana legalization and commercialization was associated with a 
lower risk perception reported among all age groups.  
This reduction of social costs presents an opportunity for the individual to more 
equally weigh the costs and benefits associated with each substance, thus allowing for a 
potential substitution effect. For example, if an individual is choosing to partake in 
marijuana use or alcohol consumption, the costs may focus on other more immediate 
consequences related with each drug (e.g. intoxication effects, health concerns/medical 
benefits, hangovers, availability, price values) instead of having to consider the legality 
of one substance over the other. Overall, the consequences, normalization, and stigma 
associated with marijuana usage are all affected by changes in marijuana policy. The 
decrease in these informal sanctions, as well as, more acceptable attitudes among friends, 
parents, or the general community will likely all exert some sort of influence on the 




Another factor for adolescents to take into consideration may be the prices of both 
alcohol and marijuana; which can vary drastically across states. In an attempt to reduce 
underage drinking, a number of alcohol policies have been implemented in the United 
States, making alcohol availability more difficult and expensive. Some states have 
attempted to control access to alcohol by decreasing the hours of sale, not allowing the 
sale of alcohol in corner stores, implementing an excise tax, or even containing “dry 
counties” - which forbid the sale of any kind of alcoholic beverage (Greenfield & 
Gresibecht, 2008; Frendreis and Tatalovich, 2010). Prior research shows that stronger 
state alcohol policies and higher beer excise taxes are associated with lower risk of 
escalating alcohol consumption among underage youth (Fairman, Simons-Morton, 
Haynie. Liu, Goldstein, Hingson, & Gilman, 2019).  
Similarly, the prices of marijuana also vary drastically by state and the amount of 
time since legalization. Washington and Colorado both saw a sharp increase in marijuana 
prices immediately following the market’s opening (Smart, Caulkins, Kilmer, Davenport, 
& Midgette, 2018; Orens, Light, Lewandowski, Rowberry, & Saloga; 2018). However, 
prices soon decreased to reflect the more current, nationwide trends of decreasing prices 
as the marijuana industry expands (Cannabis Benchmarks, 2018). Since the availability 
and prices of both alcohol and marijuana will vary from state to state, these factors will 
likely be an important part in the youth’s decision-making process, which is entirely 
dependent on where they live.  
Apart from this state variation, actual price comparisons between alcohol and 




dose” of marijuana or THC as there is for alcohol – a standard drink in the United States 
contains 14 grams of pure alcohol (NIAAA, 2018). This makes directly comparing costs 
by price indexes of each substance difficult; however, several informal sources, 
consisting of interviews and online prices reported by the public, generally conclude 
marijuana to be cheaper (Paul, 2018; Price of Weed, 2019). Furthermore, calculating 
dosages of the psychological active component of marijuana will also vary by the 
individual user, method of consumption, and strain of marijuana (Barrus, Capogrossi, 
Cates, Gourdet, Peiper, Novak, Lefever, & Wiley, 2017). Similar to alcohol types, 
different strains of marijuana contain different THC percentages. A recent study reporting 
THC levels in commercial marijuana samples across several U.S, cities found ranges of 
averages from 19% THC in Seattle, WA, to around 15% in Denver, CO, Sacramento, 
CA, and Oakland, CA. (Vergara, et al., 2017). 
In an attempt to standardize portions of marijuana, more current estimates have 
adjusted the mean weight of marijuana in a typical joint of approximately 0.32 grams 
(Ridgeway & Kilmer, 2016). Using these standards, we can make rough price 
comparisons. For example, we could compare the average price of a mid-quality joint to 
the average 6-pack of beer, both of which might be shared amongst individuals whom are 
not considered heavy users with high tolerances. Assuming most adolescents are not 
considered heavy users, it is reasonable to assume that these measures should be 
generalizable to the population of interest. Since marijuana prices generally tend to 
decrease in recreational or medically legal states, a joint may cost anywhere from $2.21 
in Oregon up to $3.90 in North Dakota – the District of Columbia has substantially higher 




of Weed, 2019). These prices were calculated from the average price of an ounce in each 
medical and recreational state. On the other hand, the national average for a 6-pack of 
beer, ale, and other malt beverages in 2018 was around $9.03 (United States Department 
of Labor, 2019). These estimates are intended to serve as an average, middle ground 
reference for a direct price comparison of servings, which show marijuana to be 
substantially cheaper than alcohol, even in the most expensive locations. Since many 
adolescents do not have a consistent flow of income, these cost savings could pose a 
significant influence on one’s decision to substitute substances.  
There are multitudes of individual and/or societal factors that could influence 
one’s substance use patterns, these influences can range across income levels, social 
classes, social networks, drug cultures and policies (Subbaraman, 2016). These 
theoretical approaches will be important to consider when researching the complex 
epidemiology of substance use behaviors. As for the previous literature surrounding the 
extent of these behaviors on a substitution or complementary effect, it is generally 
inconclusive. In addition, there have been no previous studies, to my knowledge, which 
have explored this relationship since the introduction of recreational marijuana laws in 
the United States. The increased acceptability and accessibility that comes with 
recreational laws may allow researchers to more accurately understand the true 
relationship regarding usage of both substances. Nonetheless, while the previous 
literature is limited, many studies have attempted to uncover whether a substitution or 





2.5. Empirical Research on the Relationship Between Marijuana and Alcohol Use 
 
 Two longitudinal studies have addressed this question by studying adolescents 
and young adults. Pacula (1998) examined the effects of state-level beer taxes on alcohol 
and cannabis use frequency in the past 30 days using the National Longitudinal Survey of 
Youth (NLSY) 1979 cohort (N=8,008).  This study found support for alcohol and 
marijuana to be complementary: doubling the beer tax reduced the probability of drinking 
by 3.2% but also decreased the probability of cannabis use by 11.4%. Pacula (1998) also 
found further complementary support by assessing the effects of marijuana 
decriminalization, which appear to significantly predict increase alcohol usage. This 
support was found while controlling for other factors such as alcohol and cannabis prices 
and the ratio of crimes to officers in each state. Another longitudinal study of youth 
examined the effects of medical marijuana laws and found that time-varying state-level 
medical marijuana laws were not significantly related to past 30-day alcohol use 
(Anderson, Hansen, & Rees, 2011). This study is of particular interest to this thesis due to 
its ability to potentially capture the effects of increased accessibility to marijuana 
following the passage of medicinal laws.  
Apart from these two longitudinal studies, the majority of studies on youth and 
the substitution effect rely on cross-sectional surveys. This could serve as a limitation 
when studying substitution because researchers are unable to establish a temporal 
ordering for changes in consumption. One of the first studies published to observe the 
substitution effect took place in response to Operation Intercept, an anti-drug measure 
implemented by President Nixon in 1969. This process closed the Mexican/American 




Jamison, & Rosenblatt, 1970). The study consisted of a sample of university students and 
free clinic patients from Los Angeles, California. Of those who had used cannabis more 
than 10 times, reported a 44-51% decrease in usage frequency as a result of cannabis 
unavailability. The vast majority of these respondents (76-84%) reported an increase in 
alcohol use and other drugs in response to the cannabis shortage (McGlothlin et al., 
1970).   
Andersen, Hansen, and Rees (2013) also examined this relationship using the 
Behavioral Risk Factor Surveillance System to explore the impacts following the 
legalization of medical marijuana. Findings support evidence for a substitution effect by 
showing legalization to be associated with reductions in heavy drinking – primarily 
among those aged years 18 through 29. In addition, they found legalization to be 
associated with a 5% decrease in beer sales.  
Several studies have attempted to capture the temporal ordering for changes in 
consumption using various cross-sectional designs. For example, a study using pooled 
cross-sectional data obtained from the Harvard SPH College Alcohol Study survey for 
the years 1993, 1997, and 1999 showed that higher beer taxes were related to lower 
alcohol and cannabis use and that the price of cannabis was negatively related to alcohol 
and cannabis use (Williams, Pacula, Chaloupka, & Wechsler, 2004). The decreased usage 
of both substances suggests that the substances were potentially being used as 
complements – as the price of one substance increased, the usage rates of both substances 
dropped correspondingly, rather than just the immediate impacted substance. This study 




Contrarily, a study conducted by DiNardo and Lemieux (2001) observed a 
substitution effect by analyzing the impacts on usage rates after the rise of the minimum 
legal drinking age from 18 to 21 in the 1980’s. A sample of U.S. high schoolers was used 
from the 1982-1989 Monitoring the Future survey which measured past 30-day cannabis 
and alcohol consumption. Results indicated that increasing the drinking age did decrease 
alcohol use by 4.5% but increased cannabis use by 2.4% (DiNardo & Lemieux, 2001). A 
more recent analysis of the minimum legal drinking age using the 2002-2007 National 
Survey on Drug Use and Health showed that as young adults reached the minimum legal 
drinking age of 21, a sharp decrease in marijuana usage can be observed and 
accompanied by a significant increase in alcohol usage in the past 30 days, suggesting a 
possible substitution effect among young adults (Crost & Guerro, 2012). These findings 
did contradict an earlier, similar study using the NLSY97 which found turning 21 to be 
associated with an increase in marijuana and alcohol use (Yörük and Yörük, 2011). 
However, the sample of this study was restricted only to respondents who had used 
cannabis at least once since last interviewed. A re-analysis of this study was later 
conducted by Crost and Rees (2013) who then found no significant changes of cannabis 
use at 21 and thus no evidence of complementary support. This re-analysis poses an 
interesting suggestion, that current or more frequent marijuana users may complement 
more than the general population as a whole.    
Based on their findings, DiNardo and Lemieux (2001), Crost and Guerrero 
(2012), and Anderson, Hansen, and Rees (2013) have all suggested that as marijuana 
becomes more accessible among states, that young adults are likely to respond by 




effects of these laws as they only consisted of states with medical marijuana laws. In 
these states, marijuana can only be purchased by individuals who obtain a medical 
marijuana card – for those who qualify, cards are issued by the state, following the 
recommendation of a physician. These individuals may be less likely abuse their medical 
card by illegally distributing marijuana to adolescents. However, with the passage of 
recreational laws, marijuana becomes regulated similarly to alcohol, thus significantly 
increasing the opportunity of accessibility for adolescents. This thesis assesses whether 
the suggested substitution or complementary effects exist for adolescents under more 
liberalized policies which include recreational marijuana laws. 
3.  The Proposed Study 
 
The purpose of this research is to identify whether a suggested substitution or 
complementary effect exists under more current policies which include recreational use 
marijuana. This relationship is tested using the following four hypotheses. H1: States 
with greater accessibility to marijuana through legalization will experience an increase in 
marijuana use among adolescents. Support for this hypothesis could be explained by the 
increased acceptability and accessibility that comes with marijuana legalization. These 
factors may provide more opportunities for individuals to use and/or justify marijuana 
usage, thus it is probable to observe an increase in usage. The direct alternative to these 
circumstances would be observed in the second hypothesis, H2: States with greater 
accessibility to marijuana through legalization will experience a decrease in marijuana 
use among adolescents. While this relationship may seem unintuitive, it is possible that 




more difficult for teenagers to obtain cannabis. Of course, this assumes that adolescents 
would not have access to the legal market, which may be unreasonable in some states.  
Upon observing an increase in marijuana use in Hypothesis 1, the combination of 
support with the third hypothesis is used to test for a substitution effect. H3: States with 
greater accessibility to marijuana through legalization will experience a decrease in 
alcohol consumption among adolescents. In other words, these hypotheses propose that 
as marijuana usage is normalized and increases, alcohol use will correspondingly 
decrease. This decrease in alcohol consumption could be attributed to a substitution effect 
with marijuana usage since legalization now provides more equally available options of 
another substance that some may favor over alcohol. Conversely, we could observe a 
complementary effect with usage rates of both substances increasing together, allowing 
for a direct alternative hypothesis. H4: States with greater accessibility to marijuana 
through legalization will experience an increase in alcohol consumption among 
adolescents. If a complementary effect is taking place, a significant increase in alcohol 
use can be expected. This complementary effect would be further confirmed with the 
support from both Hypothesis 1 and Hypothesis 4. Overall, the combination of these four 
hypotheses represent a two-tailed hypothesis test of the effects of marijuana legalization 
on adolescent alcohol consumption. 
For this study, marijuana and alcohol use are measured primarily by the frequency 
of usage in the last 30 days. Understanding marijuana legalization’s impacts on substance 
use patterns should be of particular interest for public health and safety concerns. 




indirect effects on changes in use of other more harmful substances could potentially 
outweigh the concerns of marijuana related outcomes. 
3. 1. Data  
To test these hypotheses, I use responses to survey questions of the Youth Risk 
Behavior Surveillance System (YRBSS). These data include responses from 894,287 
adolescents across 38 states over the years 1995 to 2017. In addition, information on the 
variations of state laws passed and implemented on the legalization status of marijuana 
are used to test these hypotheses 
The data from the YRBSS is a collected cross-sectionally from a school-based, 
national survey of youth in grades 9 through 12. The survey monitors six different 
categories of health risk behaviors that contribute to the leading causes of death and 
disability among young adults – including measures of alcohol and drug use. These data 
are collected biennially since 1991, using a national school-based survey conducted by 
the CDC which includes state, territorial, tribal, and large urban school districts. The 
ongoing surveys are conducted beginning in July of the preceding even-numbered year 
(e.g., in 2010 for the 2011 cycle) when the questionnaire for the upcoming year is 
released and continues until the data are published in June of the following even-
numbered year (e.g., in 2012 for the 2011 cycle). For this particular study, I will be only 
be using the years 1995 through 2017 as a sufficient window to capture the variation in 
state marijuana laws. To test my hypotheses, the unit of analysis will be the individual. 
The dependent variables used to test my hypotheses are continuous and include 




variables, all responsive ordinal variables will be recoded to a count variable by taking 
the midpoint of each range within the scale.  
 To capture 30-day alcohol and marijuana use, responses are recorded on similar 
scales in response to the questions: During the past 30 days, on how many days did you 
have at least one drink of alcohol? During the past 30 days, how many times did you use 
marijuana? The original measurement for the alcohol use scale was distributed 
accordingly: 1) 0 days, 2) 1 to 2 days, 3) 3 to 5 days, 4) 6 to 9 days, 5) 10 to 19 days, 6) 
20 to 29 days, 7) all 30 days. The recoded count variable (alcohol) is measured as: zero, 
one, four, seven, fifteen, twenty-five, and thirty days.  Marijuana use was measured 
similarly, capturing the number of times consumed in 30 days using a 6-point scale:  1) 0 
times, 2) 1 to 2 times, 3) 3 to 9 times, 4) 10 to 19 times, 5) 20 to 39 times, and 6) 40 or 
more times. The recoded count variable is coded as: zero, one, six, fifteen, thirty, and 
forty times.  
In addition to these data, each individual observation includes the state from 
which the response was collected. It is also important to note that these data do not 
include the District of Columbia, which is therefore be excluded from this analysis. For 
the independent variable, the state of each respondent is coded nominally according to the 
legal status of marijuana for the respective year (Table 2). Due to the complexity of each 
state’s laws, marijuana legality is separated into three general categories: (3) legalized 
adult recreational use, (2) legalized for medicinal use, or (1) no legal adult marijuana 
program (Table 2). This final and most restrictive category includes both the four states 
with no public access marijuana programs and the fifteen states with narrowly defined 




For my analysis, these legalization categories are operationalized with a dummy 
variable for each year, depending on whether they are legalized recreationally or 
medicinally – with 0 signifying illegality in both cases. All recreational states are coded 
as (1) for both the medical and recreational variables, since there are no recreational 
states without a medical marijuana program.   Additionally, recreational and medical will 
be defined by two separate variables – one signifying the actual passage of the law and 
the other representing its actual implementation and opening of each market. This is an 
important distinction to make when considering the theoretical approach of Rational 
Choice Theory; as legalization alone should lead to a softening of norms surrounding 
marijuana and thus decreases the informal costs associated with usage. Additionally, 
adolescents will always need some form of a “dealer” to provide them with marijuana 
whether or not dispensaries are up and running. However, the actual availability and 
opportunity to obtain marijuana may potentially increase once the legal marijuana market 
opens up - thus it is important to differentiate and understand the impacts following both 
of these scenarios. 
A dummy variable is also included to control for decriminalization within 
fourteen states to help capture some of the variation across state laws. While this is one 
variation of medical marijuana laws that I am able to capture in these data, other 
variations between medical states can be extensive and will be more difficult to measure. 
For example, some medical states are much more restrictive on their criteria regarding 
who is qualified for a medical marijuana license, fewer physicians are licensed with the 
state’s medical marijuana program, and there are a limited number of dispensaries 




marijuana states have a much broader criteria for qualifying conditions, more enthusiasm 
among physicians participating in the program, and dispensaries are much more abundant 
(Marijuana Policy Project, 2019). While capturing the exhaustive variations of laws 
between medical marijuana states is beyond the scope of this thesis, it is a limitation 
which should be acknowledged when interpreting any results.  
Furthermore, a dummy variable has been added to account for a spillover effect in 
non-recreational states who share a border with recreational states. Previous studies have 
found that after Oregon opened recreational stores in 2015, following Washington’s store 
openings in 2014, Washington retailers along the Oregon border experienced a 41% 
decline in sales immediately following Oregon’s market opening (Hansen, Miller, & 
Weber, 2017). Another study observed that recreational marijuana legalization in the 
states of Colorado and Washington has been associated with a significant positive impact 
on marijuana possession arrests in neighboring states with a shared border – particularly 
in counties that shared a border (Hao, Cowan, 2017). 
While it is plausible that there may be increased enforcement and vigilance for 
marijuana trafficking within the neighboring counties, results nonetheless suggest that 
recreational marijuana is indeed being transported into neighboring states. In addition, it 
is worth noting that this study only found marijuana possession arrests to be entirely 
concentrated among adults, with no significant findings for juvenile possession. 
However, with the limited research surrounding these more modern laws, it is crucial to 
build upon previous findings and so this study also controls for a spillover effect in 
shared border states of recreational marijuana. For this particular data set, there are a total 




Additional control variables used in this study account for other substance use 
patterns and individual demographic characteristics. First, I include the 30-day alcohol or 
marijuana use as a control in the models that use the other substance as the dependent 
variable. When considering the complex epidemiology of one’s decision to substitute or 
complement substances, we can assume that more than just marijuana legality will 
influence this decision. Additionally, other individual characteristics include age for all 
years between 12 through 18 years old, sex (male or female), and race which is divided 
into four primary categories: white, black, Hispanic, and all other races. Table 1 includes 
the names and descriptions of the provided survey responses used for this study, as well 
as their operationalizations.  
The data used in this analysis consist of several strengths that are beneficial for 
the current study. Primarily, it is a relatively large sample (N=894,287) over an extended 
amount of time (twenty-two years) that includes the variation of state laws over time, 
including up to 5 years of recreational legality – a measure previous research has 
significantly lacked. In addition, while this is not a complete national sample of all 50 
states, these data include an impressive majority of (38) states which are distributed 
across the country (Table 2). This aspect is important because the conclusions of this 
study will remain fairly generalizable to the rest of the country, since the data are not 
condensed to a specific state or region. However, this generalizability should be taken 
lightly as the states were not randomly selected.  
Furthermore, states with some form of legalization and accessibility, may capture 
more accurate marijuana usage rates as the substance becomes more normalized. 




in non-legal states, as they may be less willing to indicate illegal substance use. This is 
likely to be more prevalent in states with stricter marijuana laws or during time periods 
before legalization efforts, thus portraying a possible underrepresentation of true usage 
rates. An even bigger consequence of this, is that it could exaggerate the differences 
between usage in legal versus illegal states, leading to a Type I error.  
This analysis does face other limitations, as well. Because the data are pooled 
cross-sectional, individuals are only surveyed once, which limits my ability to establish a 
definite, causal relationship. Additionally, only a subset of the YRBSS surveys are used 
in this dataset. State YRBSS datasets are owned and controlled by the health and 
education agencies that conducted the surveys. A number of these agencies have not 
given the CDC permission to include their data in the combined dataset, which was used 
for this analysis. Furthermore, some state surveys and/or previous years exclude some of 
the questions used in the 2017 YRBSS survey. As a result, missing variables preclude my 
ability to measure other patterns of substance use, including binge drinking, in these 
analyses. Binge drinking is one of the most detrimental and popular alcohol consumption 
methods among young adults and adolescents and is an even more relevant public health 
concern than frequency of alcohol consumption.  
While these data are among the first to include recreational states, the timeline 
since the passage of most state’s legislation is still relatively short. This raises concern 
when observing trends over time, considering that the first states to legalize recreational 
marijuana – Colorado and Washington – did so only in 2012. As a result, the analysis of 
recreational laws is limited to observing changes within approximately a five-year time 




states with some of the oldest recreational laws, Washington and Oregon. Following 
Colorado’s legalization (2012), Alaska is the next state with the oldest recreational laws 
(2014) in this particular data set. While this is not detrimental to the  
analysis, the relatively short time frame may be important to consider upon establishing 
conclusions.  









Past 30 days alcohol 
use 
1. 0 days 
2. 1 to 2 days 
3. 3 to 5 days 
4. 6 to 9 days  
5. 10 to 19 days 
6. 20 to 29 days 











Past 30 days marijuana 
use   
1. 0 times 
2. 1 to 2 times 
3. 3 to 9 times 
4. 10 to 19 times 
5. 20 to 39 times 







    







Race of Respondent 
 
1. “White” 
2. “Black of African 
American” 
3. “ Hispanic/Latino ” 











12. 12 years or 
younger 
13. 13 years old 
14. 14 years old 
15. 15 years old 
16. 16 years old 
17. 17 years old 






Table 2. States and Years with Corresponding Legalization Code 
 
 
STATE   1995 1997 1999 2001 2003 2005 2007 2009 2011 2013 2015 2017 
AK 1    2  2 2 2 2 3 3 
AL 1 1 1 1 1 1  1 1 1 1  
AR 1 1 1 1  1 1 1 1 1 1 2 
AZ     1 1 1 1 2 1 2 2 
CA           2 3 
CO      2  2 2   3 
DE   1 1 1 1 1 1 2 2 2 2 
FL    1 1 1 1 1 1 1 1 2 
HI 1 1 1   2 2 2 2 1 2 2 
IA  1    1 1  1   1 
ID    1 1 1 1 1 1 1 1 1 
IL 1      1 1 1 2 2 2 
KS      1 1 1 1 1  1 
KY  1   1 1 1 1 1 1 1 1 
LA  1     1 1 1 1  1 
ME 1 1  2 2 2 2 2 2 2 2 3 
MI  1 1 1 1 1 1 2 2 2 2 2 
MO 1 1 1 1 1 1 1 1  1 2 2 
MS 1 1 1 1 1  1 1 1 1 1  
MT 1 1 1 1 1 2 2 2 2 2 2 2 
NC 1   1 1 1 1 1 1 1 1 1 
ND 1  1 1 1 1 1 1 1 1 1 2 
NE     1 1   1 1 1 1 
NH 1    1 1 1 1 1 2 2 2 
NJ    1  1  1 2 2   
NV 1 1 2 2 2 2 2 2  2 2 3 
NY  1 1  1 1 1 1 1 1 2 2 
OK     1 1 1 1 1 1 1 1 
PA        1   1 2 
RI  1  1 1 1 2 2 2 2 2 2 
SC 1 1 1   1 1 1 1 1 1 1 
SD 1 1 1 1 1 1 1 1 1 1 1  
TN     1 1 1 1 1 1 1 1 
UT 1 1 1 1 1 1 1 1 1 1  2 
VA         1 1 1 1 
WI  1 1 1 1 1 1 1 1 1  1 
WV 1 1 1  1 1 1 1 1 1 1 2 





3.2.  Methods 
 
In this thesis, given that my dependent variable is a count variable, with a possibly 
over dispersed variance, I use a negative binomial model in order to test my hypotheses.  
This model uses subscripts: i for the individual, j for the state, and t for the year. 
Additionally, my models are also clustered by state, as the error terms within states will 
be more correlated than across states. In order to absorb some of the variation within 
states such as: price differences, price changes, the presence of dispensaries, and state 
alcohol policies, I include fixed effects for the state, which is depicted by bj in equation 1. 
Year fixed effects (bt) are included to account for systematic effects that are unique to 
each year for all states. By controlling for these fixed effects, the estimates are 
invulnerable to unmeasured state to state or year to year changes in the data.  
The recreational and medical variables represent the dummy variables for either 
the initial passage of laws or the actual implementation of laws, respectively. By running 
these two separate models, I am be able to conduct a sensitivity analysis in order to 
observe the impact of mere legalization versus increased accessibility.  
In addition, after further observation of the usage rate variables, there appears to 
be a consistent downward trend in alcohol use since the year 1995 (Appendix C). 
Marijuana use also follows a similar trend but to a lesser extent. While some of this may 
be accounted for on a national level by fixed effects, it is likely that each state may also 
have its own variation of usage trends. It is important to account for both trends because 
changes in local trends can distort the estimates of state laws. To control for this factor, I 
𝑌ijt = 	𝛽o + 𝛽1recreational𝑗𝑡 + 𝛽2medical𝑗𝑡 + 𝛽3𝑠pillover𝑗𝑡 + 𝛽4decriminalization𝑗𝑡





include the estimated trend of alcohol and marijuana use for each state generated from 
negative binomial models (See Equation 2). In the primary analyses, each substance’s 
usage trend is controlled for when the respective substance is used as the dependent 
variable.  
𝑦G = 	 𝛽o + 𝛽1year (2) 
 In this study, the final model is used a total of four times, twice with each substance 
(alcohol or marijuana) as the dependent variable. Significant results (p<0.05) are 
interpreted and applied to each hypothesis. The support of Hypothesis 1 would be given by 
significant, positive coefficients for my primary independent variables measuring legality 
when using 30-day marijuana use is used as the dependent variable. Hypothesis 2 would 
be supported by a significant, negative coefficient with my primary independent variables 
when 30-day marijuana use is used as the dependent variable. Using 30-day alcohol use as 
the dependent variable, a significant, negative coefficient of my primary independent 
variables would propose support for Hypothesis 3. Lastly, Hypothesis 4 would be supported 
by a significant, positive coefficient of my primary independent variables when using 30-
day alcohol consumption as the dependent variable. A suggestive substitution effect would 
be provided by support from Hypothesis 1 and Hypothesis 3. Whereas a complementary 
would be suggested by support from Hypothesis 1 and Hypothesis 4.  
 
 3.3.  Results 
  
 In this section I first present the descriptive statistics to summarize the primary 
dependent and independent variables. I then present the results of the negative binomial 
models and sensitivity analyses used to test the hypotheses. The results are first presented 




passages and/or actual implementation. These results are then interpreted and applied to 
the four hypotheses. Finally, this section ends with a supplementary analysis for the 
purpose of further observation and future research suggestions. 
3.3.1.  Descriptive Statistics 
 
Table 3 provides descriptive statistics which consists of the means, standard 
deviations, 95% confidence intervals, and the minimum and maximum measures for the 
independent and dependent variables of interest. The 30-day alcohol use variable consists 
of 819,935 responses with a mean of 1.94 and a standard deviation of 4.77 – these 
numbers suggest that the average US high school student drinks roughly 1 to 2 days a 
month. The 30-day marijuana use variable consists of 863,592 responses with a mean of 
2.85 and a standard deviation of 8.79. These descriptive statistics suggest the average US 
high school student uses marijuana around 2 to 3 times a month. While at first glance, 
this may appear to suggest higher usage rates than alcohol, it is important to clarify the 
distinction that alcohol is measured in days and marijuana use is measured in number of 
times – as an individual can use marijuana multiple times per day. Additionally, the 
measurement scale for marijuana contains a much larger range for each measurement 
point and has a higher maximum value than alcohol. The combination of these factors 
may partly explain the large standard deviation – overall this variable is much more 
spread in its measurements and responses. 
Table 3 also includes the primary usage measures separated by state laws. The 
table confirms that majority of responses are indeed from illegal states, followed by 
medical, and then recreational. Table 3 displays that the means and standard deviations 




increase in the mean marijuana use states legalize medicinally; however, both measures 
again drop below the original illegal statistics for recreational states.  
To further understand usage in these data, Table 4 provides the joint probability 
distribution showing the proportions of whether or not individuals used alcohol and/or 
marijuana in the past 30 days. The majority of students appear to abstain from both 
alcohol and marijuana use whereas only 15.5% had consumed both. Unsurprisingly, there 
was more consumption of only alcohol and no marijuana 21.1%, compared to only 
marijuana and no alcohol 3.8%.  
 
 








VARIABLE    N        Mean      SD       Min. Max.    95% CI    
30 Day Alcohol Use  819,935    1.94        4.77          0       30      [1.93, 1.95] 
30 Day Marijuana Use  
 
863,592    2.85        8.79          0       30      [2.83, 2.87] 
ILLEGAL 
   30 Day Alcohol Use  
 
570,954    2.14        4.99          0       30      [2.13, 2.15]    
   30 Day Marijuana Use  
 
599,230    2.81        8.73          0       40      [2.78, 2.82]   
MEDICAL 
   30 Day Alcohol Use  
 
233,540    1.51        4.25          0       30      [1.49, 1.52]   
   30 Day Marijuana Use  
 
247,838    2.98        8.99          0       40      [2.95, 3.02]   
RECREATIONAL 
   30 Day Alcohol Use  
 
15,441      0.95        3.37          0       30      [0.90, 1.00]     
   30 Day Marijuana Use  
 
16,524      2.57        8.37          0       40      [2.44, 2.69] 
 
State Legal Status 
 
 





Table 4. Probability Distribution of 







3.3.2.  Model Results 
 
The following results include an overview of the two separate regression models 
for each substance, observing the impacts of initial legalization efforts versus the actual 
openings of medical and recreational markets. Significant results are interpreted using the 
incidence rate ratio, which calculates the ratio of two incidence rates. This is done by 
dividing the incidence rate among the exposed portion of the population by the incidence 
rate in the unexposed portion of the population to give a relative measure of the effect of 
a given exposure and thus approximates the relative risk of the occurrence. These models 
are used to conduct a sensitivity analysis between law passage and implementation and 
results from both are be applied to my hypotheses. 
Marijuana 
To test Hypothesis 1 and 2, I examine the impacts that marijuana laws and 
dispensaries have had on either the increase or decrease of marijuana usage rates. I have 
provided the results of each respective negative binomial regression for Model 1 and 
Model 2 (Table 5). Model 1 examines the effect directly after the passage of either 




        MARIJUANA 
 
  NO                     YES 
NO .595 .038 




after medical or recreational dispensaries had officially opened. The significant results of 
these models are interpreted using the incidence rate ratio and later applied to test the 
hypotheses.  
Model 1, which observes 30-day marijuana use after law passages, suggests a 
negative relationship between recreational and medical marijuana laws with 30-day 
marijuana use: however, these variables are insignificant. Thus, these results suggest that 
there is no significant increase in marijuana use among adolescents following the passage 
of medical or recreational marijuana laws. However, decriminalization appears to have a 
slight significant increase in marijuana use, by a rate of 1.052 (p<0.05). 
The additional substance use pattern in the model is significant and suggests a 
positive relationship with 30-day marijuana use. This positive relationship with alcohol 
may suggest the possibility that individuals who are already using alcohol may be 
complementing with marijuana. However, this relationship could also be spurious. 
Model 2, which measures 30-day marijuana use after the opening of medical and 
recreational markets is insignificant for all primary variables of interest. In comparison to 
Model 1, decriminalization has also lost its significance. This model further confirms that 
there is no significant increase (or decrease) in marijuana use among adolescents 
following the opening of medical or recreational markets. Additionally, the remainder of 









Table 5. Results of Negative Binomial Regression 
30-day 
Marijuana use 
Model 1 (laws passed) 
b 
(SE) 





















































































*indicates p-value<0.05, **indicates p-value <0.01, ***indicates p-value <0.001 
 Alcohol 
To test Hypotheses 3 and 4, I examine the impacts marijuana laws and 
dispensaries have had on either an increase or decrease in alcohol usage rates. I have 
provided the results of the separate negative binomial regressions from Model 3 and 
Model 4 below (Table 6). Model 3 examines the effect directly after the passage of either 
medical or recreational laws. Model 4 was run similarly but observes the effect only after 




After observation of Model 3, there is a significant negative relationship of 30-
day alcohol use and the passage of recreational marijuana laws by a factor of 0.891 
(p<0.01). While the directions of the other variables of interest are also negative, none of 
these are significant. 
Apart from the primary variables of interest, there again appears to be a trend 
among substance use. For individuals who have used marijuana in the last 30 days, there 
is a significant expected increase of alcohol use by a rate of 1.074 (p<0.001). This 
relationship once again suggests that individuals who are already using marijuana may be 
complementing with alcohol.  
When conducting a sensitivity analysis with Model 4, which observes 30-day 
alcohol use in response to the openings of recreational and medical marijuana 
dispensaries, there is still a suggestive decrease in alcohol use associated with the 
opening of both dispensary types; however, none of these are significant (Table 6: Model 
4). Additionally, the directions and significance of all other control variables are 











Table 6. Results of Negative Binomial Regression 
30-day 
Alcohol use 
Model 3 (laws passed) 
b 
(SE) 









































































*indicates p-values<0.05, **indicates p-value <0.01, ***indicates p-values <0.001 
Hypothesis 1 
The first hypothesis in this thesis proposes that states with greater accessibility to 
marijuana through legalization will experience an increase in marijuana use among 
adolescents. The increase in accessibility was defined as the passage of recreational and 
medical marijuana laws, as well as the official openings of recreational and medical 
markets. To assess my hypothesis, a negative binomial regression was conducted to 




sensitivity analysis was conducted for law passage and implementation. The results 
indicated that none of my independent variables of interest were significant to support 
this hypothesis. However, there may be some limited support provided by a significant 
increase of marijuana use following decriminalization in Model 1 (Table 5).  
Hypothesis 2 
As for the alternative hypothesis, the was no support suggesting that states with 
greater accessibility through legalization will experience a decrease in marijuana use 
among adolescents. None of the models indicated a significant decrease in 30-day 
marijuana use following the passage or implementation of any legislation. 
Hypothesis 3  
The third hypothesis in this study proposes that states with greater accessibility to 
marijuana through legalization will experience a decrease in alcohol consumption among 
adolescents. This hypothesis was only explicitly supported by Model 4 (Table 6), 
showing a significant decrease in 30-day alcohol use at a rate of 0.891 after the initial 
passage of recreational laws (p<0.01).  
Hypothesis 4 
The fourth hypothesis proposes a direct alternative to Hypothesis 3, which 
suggested that states with greater accessibility to marijuana through legalization will 
experience an increase in alcohol consumption among adolescents. The results of the 
negative binomial regression showed no significant support for this hypothesis across 
Model 3 and Model 4 (Table 6). In other words, there was no significant increase for 





3.3.3.  Substitution Effect 
 
The hypotheses thus far have provided limited support for a possible substitution 
effect following marijuana legalization. While Model 4 (Table 6) shows support for 
Hypothesis 3, suggesting a significant decrease in alcohol use following the passage of 
recreational laws, there is no suggested increase in marijuana rates for recreational laws. 
However, decriminalization does suggest a significant increase in 30-day marijuana use 
in Model 1 (Table 5). When comparing different types of legislation within these models, 
these are the only significant results across all four models that may indicate the 
possibility of a substation effect. In addition, both of these results are in the models 
observing changes after the initial passage of marijuana laws.  
While the significant responses are observed for separate laws, this may pose some 
evidence that substitution patterns could be taking place. 
3.3.4.  Complementary Effect 
 
A complementary effect would have been suggested by support for Hypothesis 1 
and Hypothesis 4; however, both these hypotheses were unsupported by the primary 
variables of interest. While there was an increase in marijuana use for decriminalization 
in Model 1, there were no models which showed a significant increase in alcohol use 
following any sort of marijuana legalization policies.  
However, other variables among usage patterns may suggest a potential 
complementary effect among individuals who are already using both substances. Table 6 
displays a significant increase in alcohol use with an increase in 30-day marijuana use 




However, there is no support for an increase of additional individuals experiencing a 
complementary effect as a result of law changes. 
3.3.5.  Supplementary Analysis 
 
Apart from the impacts of law changes, demographics appear to be an important 
predictor in substance use. In reference to the white race variable, all race categories 
suggest a significant increase in 30-day marijuana use, except for all other races (Table 
5; Table 6). For Model 1, marijuana use is increased for black, Hispanic, and all other 
races – with black obtaining the greatest magnitude at an increased rate of 1.40 
(p<0.001). This model also suggests that being female is associated with a significant 
decrease in marijuana use compared to males at a rate of 0.65 (p<0.001). For these 
demographics, Model 2 has almost directly comparable results.  
Furthermore, age has a significant, positive correlation with marijuana use, which 
is expected. In other words, adolescents increase 30-day marijuana use by a factor of with 
each additional year of age. However, after further observation of 30-day marijuana use 
by age, there appears to be a dramatic increase in the mean of marijuana use for 12-year 
old’s (see Appendix B1). In total, 35% of 12-year old’s report using marijuana 30 or 
more times each month. When removing this age group from the model, the positive age 
coefficient remains, at a slightly lesser magnitude, but the significance remains (See 
Appendix B2). All other coefficients also remain comparable to previous models. While 
it is possible that these observations may have been recorded in error, the original age 
variable was kept in the final models as to not induce further bias.  
For alcohol use, all race categories appear to be significant, except for hispanic, in 




consume less alcohol than whites to the greatest magnitude when compared to other races 
– with an expected decrease by a factor of 0.567 (p<0.001). To a lesser extent, all other 
races appear to consume alcohol less frequently than whites, with an expected decrease 
by a rate of 0.802 (p<0.05).  
The age variables once again present an interesting trend with a dramatic increase 
in the mean of alcohol use for 12-year old’s (see Appendix B3). After removing 12-year 
old’s and rerunning the models, age remains positively significant to a lesser magnitude 
and all other variables remain fairly comparable (See Appendix B4).  
Furthermore, while other control variables measuring substance use have been 
excluded from my primary models due to missing observations, exploring the impacts of 
these variables in a separate negative binomial regression model suggest some interesting 
relationships that may be of interest for future research. However, it is worth noting that 
this model only includes 29,265 observations from the year 2017 of the total variables in 
this dataset (n=894,287).  
The removed variables include the largest number of drinking consumed in the 
last 30 days (most alcohol), number of days of alcohol consumption in lifetime (lifetime 
alcohol), and binge drinking (binge). When including these variables following initial 
law passages, results show a significant decrease in alcohol use by a factor of 0.857 
(p<0.001) in recreational states and a decrease by 0.913 (p<0.05) in medical states (See 
Appendix D1). There is also a significant decrease in spillover states by 0.424 (p<0.001); 
however, decriminalized states suggest an increase in alcohol use by a rate of 1.11 




 Furthermore, the relationships of 30-day marijuana use suggests a significant 
increase in marijuana use at a rate of 1.957 (p<0.001) for recreational laws, an increase of 
1.209 (p<0.01) for medical laws, and an increase of 8.31 (p<0.001) for spillover states 
(See Appendix D2). However, decriminalization shows a significant decrease of 
marijuana use at a rate of 0.523 (p<0.001).  
These models present further support for a substitution effect with a significant 
increase in marijuana use but a significant decrease in alcohol use for recreational, 
medical, and spillover states. Interestingly, decriminalization also supports a substitution 
effect but in the other direction, suggesting a significant increase in alcohol use and a 
significant decrease in marijuana use.  
An additional factor of these missing data is that binge drinking was only 
included on the state-level YRBSS surveys during the year of 2017 (n=69,332). 
However, when exploring the possibility of a substitution or complementary effect, binge 
drinking is an important factor to consider, since it is one of the most dangerous alcohol 
consumption patterns and most popular among teenagers and young adults. Due to the 
missing data, this will not be considered in testing my hypotheses; however, the impacts 
of marijuana laws on binge drinking will still be explored to suggest potential directions 
for future research.  
The binge drinking variable measures the frequency of binge drinking 
occurrences in the last 30 days. Binge drinking is defined by 4 or more drinks for females 
and 5 or more drinks for males in approximately 2 hours. When binge drinking is 
included in the model as the dependent variable, there is evidence of a significant 




as for spillover states with an increase of 1.31 (p<0.001) (See Appendix D3). However, a 
significant decrease in binge drinking is found following medical marijuana laws by a 
rate of 0.952 (p<0.001), decriminalization also significantly decrease binge drinking rates 
by 0.914 (p<0.001).  
While these models are limited, they suggest some interesting patterns that should 
be taken into consideration by future research. The YRBSS survey does offer extensive 
data on various substance use patterns; however, many of these responses from various 
states and previous years are unfortunately missing. Past studies have also confronted the 
limitation of lacking detailed data on substance use patterns over time. While it is still a 
common issue, future researchers should take inspiration of these limited observations to 
further study the impacts of marijuana laws on substance use and binge drinking rates 
with more complete data.  
4.  Discussion 
 
The models have thus far suggested limited support for marijuana laws impacting 
a substitution effect, particularly with the passage of recreational laws, suggesting a 
significant decrease in alcohol use. While the other variables of interest were not 
significant, the directions followed suite with a negative direction. However, there were 
no significant increases in marijuana use other than following decriminalization. While 
an increase in marijuana use is technically required to satisfy the definition of a 
substitution effect, it cannot be ruled out that this positive increase in marijuana use may 
also be related to complementing substances. However, there is no significant increase of 
alcohol use within this particular analysis. Beyond this speculation, there is no significant 




may be cases of complementing for individuals who already use both substances. Table 5 
displays a significant increase in marijuana use with an increase in 30-day alcohol and 
Table 6 reciprocates this relationship by an increase in alcohol use with an increase in 30-
day marijuana use. However, for those that may be complementing, there appears to be a 
usage of alcohol at a lesser rate than marijuana. 
In addition, race appears to be an important factor of substance use patterns, in 
reference to the white respondents. Black respondents appear to consume both alcohol 
and marijuana at higher rates than white respondents and thus may be more likely to 
complement substances. Whereas all other race respondents consume only marijuana at a 
significantly higher rate than white respondents and Hispanic respondents consume more 
marijuana. In summary it appears that certain substance use trends may be more prevalent 
among minorities.  
 Last, while the supplementary analysis is incredibly limited, it certainly gives 
incentive to further explore the relationships of substance use and marijuana laws with 
more sufficient data. These models provided significant support for a substitution effect, 
suggesting a significant decrease in alcohol use and increase in marijuana use in 
recreational, medical, and spillover states. However, this substitution relationship was in 
the reverse direction for decriminalization.  
Impacts on binge drinking were mixed but still significant. Recreational and 
spillover states suggested a significant increase in binge drinking whereas medical and 
decriminalized states suggested a significant decrease. However, the individual substance 
use patterns suggested a significant increase in binge drinking to be associated with an 




involved in substance use or the “party culture” may be at even greater risk of binge 
drinking. Given this relationship is true, increased access to alcohol or marijuana could 
pose serious consequences for these individuals. Further understanding the dynamics of 
this relationship is critical in order to properly address it. With this knowledge, schools 
and communities can more effectively disseminate information and provide education on 
the dangers associated with complementing these substances at such high usage rates.  
Nonetheless, even with the limited data, these mixed but significant findings give 
sufficient reason to pursue a better understanding on how marijuana policies impact binge 
drinking rates. When considering the detrimental effects of binge drinking and its 
popularity among adolescents, this is an important substance use pattern that should not 
be overlooked and taken into serious consideration for policy implementation. 
4.1.  Conclusion 
 
With the rapid changes in marijuana laws spanning across the country, it is critical 
to understand the underlying consequences of these policies. Previously, researchers have 
been unable to fully measure a substitution or complementary effect as marijuana has 
remained illegal in all 50 states, thus restricting access and usage. However, with 
legalization spreading across the country, alcohol and marijuana are finally becoming 
equally accessible in many states. Taking inspiration from the previous literature on a 
potential substitution or complementary effect, the recent legalization movements present 
a distinct opportunity to research these effects in a thorough and more precise manner. 
This thesis is among the first to analyze this relationship as marijuana is becoming more 




 While the findings are limited, there is marginal support for a potential 
substitution effect. Furthermore, there is ample evidence that the changes in marijuana 
policy and availability do not contribute to a complementary effect. While, there are 
mixed patterns suggesting that current users of both marijuana and alcohol may be 
substituting and/or complementing substances, there is no evidence of an increase in 
marijuana users contributing to either trend except possibly with decriminalization. In 
addition, for those that may be complementing, there appears to be a usage of alcohol at a 
lesser rate than marijuana. However, there is also no evidence of an increase in alcohol 
users that may be attributing to this. 
In summary, the provided decreases in alcohol use presented by these findings 
could contribute to a major public health benefit, especially with little to no evidence 
supporting an increase of marijuana and/or alcohol use for adolescents following 
legalization. With respect to decriminalization, these findings present an even greater 
public health benefit than a substitution effect, since no substance usages are increasing. 
As for decriminalization, this increase in marijuana use could be due to the combination 
of more relaxed norms but also no disruption to the underground market. Thus, if 
marijuana is to become decriminalized, opening some sort of legal market may actually 
contribute to a reduction in adolescent accessibility to marijuana. If this is the case, it is 
something future researchers and policy makers should seriously consider upon future 
legislation changes. 
This study, among many others, have found an apparent relationship between 
alcohol and marijuana that should be taken into consideration upon future research and 




between these two substances. The relationships found in this analysis and supplementary 
analysis certainly highlight directions that future research should consider as more 
thorough data becomes available.  
Additionally, suggestions for a stronger analysis would be able to capture more of 
the variation among marijuana laws. More specifically, while this analysis did attempt to 
control for decriminalization and spillover states, future model suggestions might include 
running separate analyses by each spillover state. While this particular analysis is beyond 
the scope of this thesis, it may be more effective in capturing the effect of the spillover 
phenomenon. 
Furthermore, it is important to highlight the difficultly in accurately measuring a 
shift in norms. While this thesis theoretically implied that law changes may influence 
norms, this is likely a reciprocal relationship. In other words, laws may also be changing 
due to a shift in norms. Taking this dynamic into consideration is an important aspect to 
consider for future researchers when trying to explain changes in trends and the 
normalization of marijuana. 
Nonetheless, while this analysis is limited, this thesis highlights potential future 
directions of marijuana policy research and brings a unique contribution of further 
understanding the substitution/complementary dynamic of alcohol and marijuana under 
more current legislation. This analysis further supports previous findings suggesting that 
there is indeed an apparent relationship between alcohol and marijuana use. While the 
causal mechanisms are still unclear, this is a relationship that should be taken into strong 







Appendix A. Cross Sectional State Identifiers 
Table 1. State and Year for 30-Day Alcohol Use and Marijuana Law Changes 
state id b Robust S.E. p-value 
2 0.2704484 0.0575044 0 
3 0.1843937 0.0620503 0.003 
4 0.0670788 0.0708791 0.344 
5 0.1422002 0.0222776 0 
6 0.1229852 0.022692 0 
7 0.0645406 0.0525673 0.22 
8 0.0711151 0.0636493 0.264 
9 0.1579233 0.0650691 0.015 
10 0.1544536 0.0636262 0.015 
11 0.0781952 0.0629664 0.214 
12 0.1195483 0.0499491 0.017 
13 0.1251085 0.064529 0.053 
14 0.0990498 0.0658482 0.133 
15 0.3851179 0.0630337 0 
16 -0.1863905 0.0196255 0 
17 0.0379186 0.0587124 0.518 
18 0.1376139 0.0582004 0.018 
19 0.3626392 0.0342534 0 
20 0.2040072 0.072316 0.005 
21 0.1305626 0.0332652 0 
22 0.1902067 0.0732499 0.009 
23 0.1394176 0.0637373 0.029 
24 -0.0253499 0.0525482 0.63 
25 0.2078132 0.0652108 0.001 
26 0.1598022 0.0243745 0 
27 0.1780049 0.0230793 0 
28 0.1600758 0.0620872 0.01 
29 0.0477923 0.0672014 0.477 
30 -0.1108677 0.0445265 0.013 
31 0.2098866 0.0554939 0 
32 0.1548434 0.0653508 0.018 
33 0.0591711 0.0647103 0.361 
34 -0.4181674 0.0677727 0 
35 0.0774408 0.0664689 0.244 
36 0.1163389 0.0647497 0.072 
37 0.0526696 0.0676668 0.436 
38 0.1484155 0.071516 0.038 
    
year    
1997 -0.0177337 0.0264671 0.503 
1999 -0.0060451 0.0342239 0.86 
2001 -0.0233265 0.0460448 0.612 
2003 -0.0343292 0.0483829 0.478 
2005 -0.0154732 0.0601644 0.797 
2007 0.0402848 0.0647086 0.534 
2009 -0.0707478 0.077519 0.361 
2011 -0.2018215 0.0807731 0.012 
2013 -0.2786989 0.0877962 0.002 
2015 -0.326628 0.0939754 0.001 
2017 -0.3635175 0.0982923 0 
_cons -3.383005 0.214546 0 
lnalpha 1.367893 0.0262775  
    





Table 2. State and Year for 30-day Marijuana Use and Marijuana Law Changes 
state id b Robust S.E. p-value 
2 -0.419864 0.0596665 0 
3 -0.2084643 0.0500463 0 
4 -0.035996 0.0655618 0.583 
5 -0.2802209 0.0277552 0 
6 -0.0447733 0.0303893 0.141 
7 -0.0541333 0.050834 0.287 
8 -0.2215737 0.0494344 0 
9 -0.1944935 0.051429 0 
10 -0.4218309 0.0609265 0 
11 -0.4069307 0.0583704 0 
12 -0.1422586 0.0451305 0.002 
13 -0.3315969 0.05895 0 
14 -0.1965802 0.053473 0 
15 -0.3106385 0.0549505 0 
16 -0.0244491 0.0390494 0.531 
17 -0.1265364 0.0427971 0.003 
18 -0.1710239 0.0494326 0.001 
19 -0.4807796 0.0513475 0 
20 -0.1373244 0.0384261 0 
21 -0.1938337 0.0415568 0 
22 -0.4671672 0.0503206 0 
23 -0.5420992 0.0641411 0 
24 -0.0017177 0.0590549 0.977 
25 -0.3917087 0.0464782 0 
26 -0.1751995 0.0223063 0 
27 -0.3335725 0.0426521 0 
28 -0.3143068 0.0492159 0 
29 -0.2017447 0.0523023 0 
30 0.0492647 0.0437195 0.26 
31 -0.2675471 0.0564965 0 
32 -0.2949802 0.0406526 0 
33 -0.1478551 0.0517786 0.004 
34 -0.7039538 0.0767141 0 
35 -0.3399924 0.0553362 0 
36 -0.2559133 0.0531934 0 
37 -0.1602009 0.055706 0.004 
38 -0.3139113 0.0499122 0 
    
year    
1997 0.2400772 0.0713347 0.001 
1999 0.3070386 0.0703584 0 
2001 0.3237555 0.0811714 0 
2003 0.3368053 0.0763871 0 
2005 0.1344671 0.07347 0.067 
2007 0.1048893 0.0746822 0.16 
2009 0.2474028 0.0645214 0 
2011 0.4672678 0.0647753 0 
2013 0.4923765 0.0729427 0 
2015 0.5102059 0.065647 0 
2017 0.4896874 0.0689998 0 
    
cons -4.426035 0.2006202 0 
    
lnalpha 2.66789 0.0266961  
    
alpha 14.40954 0.384678  





Appendix B. Age Trends 







Table 2. Results of Negative Binomial Regression of 30-day  
Marijuana Use by Legalization Excluding Age 12 Years Old 
 
marijuana b Robust SE 
   
Recreational -0.0191 0.0401 
Medical -0.0509 0.0304 
Spillover 0.0065 0.0384 
Decriminalization 0.0482 0.0256 
Alcohol 0.2315*** 0.0074 
Local Trend 0.1630*** 0.0355 
Black 0.3368*** 0.0562 
Hispanic 0.1892** 0.0552 
All other races 0.2232 0.1199 
sex -0.4335*** 0.0200 
age 0.2561*** 0.0112 












Age Mean Standard Deviation 
12 16.06113 0.4008955 
13 2.055909 0.1358481 
14 1.318954 0.0183172 
15 2.054155 0.0154426 
16 2.891121 0.0182942 
17 2.301504 0.011517 
18 4.34223 0.0341513 
Table 3. Average 30-day Alcohol Use by Age 
Age Mean Standard Deviation 
12 13.61049 0.3155662 
13 1.665292 0.1024473 
14 1.063982 0.0113946 
15 1.458097 0.0088513 
16 1.903563 0.0099441 
17 2.301504 0.011517 




Table 4. Results of Negative Binomial Regression of 30-day  
Alcohol Use by Legalization Excluding Age 12 Years Old 
 
alcohol b Robust SE 
   
Recreational -0.1280** 0.0442 
Medical -0.0283 0.0282 
Spillover -0.0579 0.0437 
Decriminalization -0.0329 0.0534 
Marijuana 0.06979*** 0.0017 
Local Trend 0.2812*** 0.0419 
Black -0.5774*** 0.0358 
Hispanic 0.0098 0.0396 
All other races -0.2333*** 0.0634 
sex -0.0595** 0.0219 
age 0.2143*** 0.0080 





















Appendix C. Trends in Alcohol Use Over Time 
Table 1. Means of 30-day Alcohol and  
Marijuana Use by Year 
 
Year 
               Mean 
Alcohol                Marijuana 
1995 2.878308 2.67734 
1997 2.951167 3.406641 
1999 2.878396 3.326383 
2001 2.668148 3.325142 
2003 2.435913 3.320846 
2005 2.177602 2.526274 
2007 2.184289 2.525268 
2009 1.911219 2.753577 
2011 1.666615 3.017072 
2013 1.470822 2.8153 
2015 1.331197 2.811382 
2017 1.171105 2.543501 
 
 





























Appendix D. Exploration of Additional Variables 
Table 1. Results of Negative Binomial Regression  
of 30-day Alcohol Use and Legalization 
alcohol b Robust SE 
   
Recreational -0.1546*** 0.0146 
Medical -0.0908* 0.0357 
Spillover -0.8588*** 0.1385 
Decriminalization 0.1042*** 0.0185 
Marijuana 0.0121*** 0.0021 
Most Alcohol 0.3732*** 0.0168 
Lifetime Alcohol 0.0196*** 0.0005 
Binge 0.0026*** 0.0078 
Black -0.0796 0.0422 
Hispanic 0.0623 0.0430 
All other races -0.1010 0.0584 
Sex 0.3747*** 0.0342 
age 0.0603*** 0.0146 
Local Trend -0.5549*** 0.1491 
*indicates p-values<0.05, **indicates p-value <0.01, ***indicates p-values <0.001 
 
 
Table 2. Results of Negative Binomial Regression  
of 30-day Marijuana Use and Legalization 
marijuana b Robust SE 
   
Recreational 0.6714*** 0.1533 
Medical 0.1901** 0.0626 
Spillover 2.1175*** 0.2557 
Decriminalization -0.6486*** 0.1427 
Alcohol 0.08359*** 0.0175 
Most Alcohol 0.2551*** 0.0161 
Lifetime Alcohol 0.0262*** 0.0014 
Binge -0.1653*** 0.0284 
Black 1.1129*** 0.2003 
Hispanic 0.5438*** 0.0905 
All other races 0.4775** 0.1461 
Sex -0.1566* 0.0683 
age 0.2309*** 0.0300 
Local Trend 1.8686*** 0.1767 




















Table 3. Results of Negative Binomial Regression  
of Binge Drinking and Legalization 
binge b Robust SE 
   
Binge 0.5482*** 0.0254 
Recreational -0.0492*** 0.0037 
Medical 0.2681*** 0.0148 
Spillover -0.0903*** 0.0070 
Decriminalization 0.4041*** 0.0167 
alcohol 0.0303*** 0.0015 
marijuana -0.8737*** 0.0592 
Black -0.1197*** 0.0439 
Hispanic -0.3737** 0.0563 
All other races 0.2293*** 0.0339 
Sex 0.2009*** 0.0174 
Age 0.8662*** 0.0169 
Local Trend 0.5482*** 0.0254 
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